Navid Nedjatian

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Polycystic Ovary Syndrome

Replacement Therapy

Top Venues

Expert review of medical devices

This page only lists publications with an associated author ORCID identifier.

Publications

Yutaka Takahashi, Beverly M K Biller, Hidenori Fukuoka, Ken K Y Ho, Michael Højby Rasmussen, Navid Nedjatian, Claus Sværke, Kevin C J Yuen, Gudmundur Johannsson
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency. Pituitary (2022)
Ji Eun Lee, Kee-Hyoung Lee, Mi-Jung Park, Seung Yang, Eun Young Kim, Young-Jun Rhie, Min-Ho Jung, Aram Yang, Shin Hye Kim, Lindsey Yoojin Chung, Su Young Ko, Young Ju Lee, Navid Nedjatian, Woo Yeong Chung
The role of growth hormone device optimization in patient-reported outcomes: real-world evidence from South Korea. Expert review of medical devices 18 (1) (2021)
Beverly M K Biller, Charlotte Höybye, Paul V Carroll, Murray B Gordon, Anna Camilla Birkegård, Nicky Kelepouris, Navid Nedjatian, Matthias M Weber
Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program. Pituitary 24 (4) (2021)